Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Nov;24(9):935-40.
doi: 10.3928/1081597X-20081101-13.

Seven-year follow-up of LASIK for moderate to severe myopia

Affiliations

Seven-year follow-up of LASIK for moderate to severe myopia

Zhaoqiang Liu et al. J Refract Surg. 2008 Nov.

Abstract

Purpose: To evaluate long-term refractive outcomes of LASIK for correcting moderate to severe myopia.

Methods: A long-term (7-year) prospective follow-up study of visual and refractive outcomes in patients who underwent myopic LASIK surgery in 1998 and 1999. Fifty-nine patients (104 eyes) of the original cohort of 75 patients underwent detailed clinical assessment at 1 and 7 years postoperatively. The main outcome measures were predictability, efficacy, safety, and stability. Topography, corneal thickness, and postoperative complications were recorded at 7 years. All patients completed a questionnaire assessing their satisfaction with the procedure.

Results: At 7 years postoperatively, 89.4% of eyes were within 0.50 diopters (D) of attempted correction, and 90.4% were within 1.00 D. All eyes had 20/40 or better vision and 94.2% had 20/20 or better. Best spectacle-corrected visual acuity was unchanged or improved in 80.8% of eyes. Eyes did not regress in refraction between 1 and 7 years postoperatively. Complications were rare and patient satisfaction with the surgery was high.

Conclusions: LASIK surgery has predictable and stable results in refractive and visual outcomes in correcting moderate to high myopia on long-term follow-up. Refractive stability is maintained over 7 years, with no evidence of progressive late-onset complications.

PubMed Disclaimer

LinkOut - more resources